Krüger J, Obenaus M, Blau IW, Hoser D, Vaegler M, Rauschenbach H, Anagnostopoulos I, Jöhrens K, Scheuplein V, Kieback E, Böhme J, von Brünneck A-C, Krönke J, Busse A, Willimsky G, Blankenstein T, Pezzutto A, Keller U, Nogai A. A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma. haematol [Internet]. 2020Sep.10 [cited 2024Sep.18];. Available from: https://haematologica.org/article/view/haematol.2024.286124